Joint Meeting of the
CDER Psychopharmacologic Drugs Advisory Committee &
FDA Pediatric Advisory Committee
September 13-14, 2004
CONSULTANTS AND GUESTS
Special Government Employee (SGE) Consultants (voting)
Norman Fost, M.D., M.P.H.
Professor of Pediatrics and Bioethics
University of Wisconsin Medical School
600 Highland Avenue
Madison, Wisconsin 53792
Charles E. Irwin, Jr., M.D.
Pediatrics/ Adolescent Medicine
University of California, San Francisco: Laurel
3333 California Street, Suite 245
San Francisco, California 94143-0503
Laurel K. Leslie, M.D., F.A.A.P.
Pediatrician/Research Scientist
Child & Adolescent Services Research Center
C/o Children’s Hospital
3020 Children’s Way, MC5033
San Diego, California 92123
Steven Ebert, Pharm. D. (Consumer Representative)
Department of Pharmacy
Meriter Hospital
202 South Park Street
Madison, Wisconsin 53715
James M. Perrin, M.D.
Center for Child and Adolescent Health Policy
50 Staniford Street, Suite 901
Massachusetts General Hospital for Children
Boston, Massachusetts 02114
Cynthia R. Pfeffer, M.D.
Professor of Psychiatry
Weill Medical of Cornell University
New York Presbyterian Hospital
21 Blooming Dale Road
White Plains, New York 10605
SGE Patient Representative (voting)
Gail W. Griffith, Washington, D.C.
Guest Speakers (non-voting)
Kelly Posner, Ph.D.
Department of Child Psychiatry
New York State Psychiatric Institute
1051 Riverside Drive
New York, New York 10032
John March, M.D., M.P.H.
Department of Psychiatry & Behavioral Sciences
Duke Child & Family Study Center
718 Rutherford Street, Room 132
Durham, North Carolina 27710
Guests (non-voting)
Samuel Maldonado, M.D., M.P.H.
(Industry Representative)
920 Route 202 South
Raritan, New Jersey 08869
Barbara Stanley, Ph.D
Department of Child Psychiatry
New York State Psychiatric Institute
1051 Riverside Drive
New York, New York 10032
Madelyn Gould, Ph.D., M.P.H.
Department of Child Psychiatry
New York State Psychiatric Institute
1051 Riverside Drive
New York, New York 10032
FDA Participants at the Table (non-voting)
Robert Temple, M.D.
Director, Office of Drug Evaluation I, CDER
Russell G. Katz, M.D.
Director
Division of Neuropharmacological Drug Products, CDER
Thomas Laughren, M.D.
Team Leader
Division of Neuropharmacological Drug Products, CDER
M. Dianne Murphy, M.D.
Director, Office of Pediatric Therapeutics,
Office of the Commissioner
Anne Trontell, M.D., M.P.H.
Deputy Director, Office of Drug Safety, CDER